Literature DB >> 29734877

HPV-Positive Oropharyngeal Squamous Cell Carcinoma among Patients Taking Adalimumab for Autoimmune Disorders.

Douglas R Farquhar1, James M Taylor2, Angela L Mazul3, Jose P Zevallos4.   

Abstract

Entities:  

Keywords:  HPV positive; adalimumab; autoimmune diseases; oropharyngeal carcinoma; squamous cell carcinoma

Mesh：

Substances：

Year:  2018        PMID： 29734877      PMCID： PMC6123284          DOI： 10.1177/0194599818774756

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN： 0194-5998            Impact factor:   3.497


× No keyword cloud information.
  5 in total

1.  Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy.

Authors:  Christina Antoniou; Maria G Kosmadaki; Alexandros J Stratigos; Andreas D Katsambas
Journal:  Dermatology       Date:  2008-02-20       Impact factor: 5.366

2.  Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study.

Authors:  Seoyoung C Kim; Robert J Glynn; Edward Giovannucci; Sonia Hernández-Díaz; Jun Liu; Sarah Feldman; Elizabeth W Karlson; Sebastian Schneeweiss; Daniel H Solomon
Journal:  Ann Rheum Dis       Date:  2014-03-11       Impact factor: 19.103

3.  Maintenance of CD8 effector T cells by CD4 helper T cells eradicates growing tumors and promotes long-term tumor immunity.

Authors:  Cheng-Tao Lin; Ting-Chang Chang; Sheng-Wen Shaw; Po-Jen Cheng; Ching-Tai Huang; Angel Chao; Yung-Kuei Soong; Chyong-Huey Lai
Journal:  Vaccine       Date:  2006-06-23       Impact factor: 3.641

Review 4.  Tumor necrosis factor blockade and the risk of viral infection.

Authors:  Seo Young Kim; Daniel H Solomon
Journal:  Nat Rev Rheumatol       Date:  2010-02-09       Impact factor: 20.543

Review 5.  The interplay between HPV and host immunity in head and neck squamous cell carcinoma.

Authors:  Anne Skou Andersen; Anne Sophie Koldjaer Sølling; Therese Ovesen; Maria Rusan
Journal:  Int J Cancer       Date:  2013-08-29       Impact factor: 7.396
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.